Founded by UK life sciences venture capital firm Medicxi, Centessa Pharmaceuticals is headed up by industry heavyweights. Saurabh Saha, who was formerly Bristol Myers Squibb Company’s head of R&D, has taken the helm as CEO, while GlaxoSmithKline plc veteran and the outgoing scientific head Operation Warp Speed, Moncef Slaoui, has been appointed chief scientific officer.
“There are significant improvements in R&D productivity that still need to happen, and that’s on improving success rates, timelines and...




